NCT01190644 · OUTCOME

Change From Baseline in Absolute Reticulocyte Count

Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Participants With Solid Tumors · Source last updated 2023-11-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: Baseline (Day 1, pre-dose) and Day 211

What was measured

Blood samples were to be collected at baseline (Day 1, pre-dose) and at Day 211 to measure the change from baseline in absolute reticulocyte count.

Analysis population: No data were collected for Change from Baseline in Absolute Reticulocyte Count.

Groups in this outcome

Sotatercept

Participants received a single 35 mg dose of sotatercept by SC injection on Day 1, Day 43, and Day 85.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Sotatercept	0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denoms

counts
group Id
OG000
value
0
units
Participants

description

Blood samples were to be collected at baseline (Day 1, pre-dose) and at Day 211 to measure the change from baseline in absolute reticulocyte count.

groups

description
Participants received a single 35 mg dose of sotatercept by SC injection on Day 1, Day 43, and Day 85.
id
OG000
title
Sotatercept

population Description

No data were collected for Change from Baseline in Absolute Reticulocyte Count.

reporting Status

POSTED

time Frame

Baseline (Day 1, pre-dose) and Day 211

title

Change From Baseline in Absolute Reticulocyte Count

type

SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice